Molecular Docking, Synthesis and Antibacterial activity of sulphdiazine drug modification and studying their PC3 by MTT

Sadiq S. Sadiq

Department of Medical Lab Technique, College of Health and Medical Technology Sawa University, Al-Muthana, Iraq

Raghad Haddad

Alkarkh university of science, Baghdad, Iraq. raghadalihaddad@gmail.com 3 Chemistry Department, College of Science, AL-Nahrain University, Jadriya, Baghdad, Iraq.

Hassan Hadi Kadhim

Chemistry Department, College of Science, AL-Nahrain University, Jadriya, Baghdad, Iraq

Abbas K. Abbas

Muthana Agriculture Directorate, Ministry of Agriculture, Al-Muthana, Iraq

Ruqaya K. Abbas

Ibnsina university for pharmacy and medical science, Baghdad, Iraq

Keywords: Imine, Sulfadiazine, Schiff base


Abstract

In this study, we report a novel imine-amoxicillin synthesis (A1-A3) by reacts Sulfadiazine with different aldehydes such as 2-bromobenzaldehyde, 4-propoxybenzaldehyde, and 4- butoxybenzaldehyde. The derivatives (A1-A3) were characterized by spectroscopic technique, such as FT‐IR and 1H-NMR spectroscopy. All the synthesized derivatives were evaluated in vitro against different microorganisms such as Bacillus subtilis, Streptococcus pneumonia, E. coli, and Bacillus subtilis by zone inhibition method. The findings demonstrated that certain derivatives exhibit superior antibacterial properties in comparison to the efficacy of the original drug. The evaluation of derivative 1 as anticancer (breast cancer) by MTT assay and give a positive result after 24 h more than 48 h.


References

J. A. Alara and O. R. Alara, "An Overview of the Global Alarming Increase of Multiple Drug

Resistant: A Major Challenge in Clinical Diagnosis," Infectious Disorders-Drug Targets

(Formerly Current Drug Targets-Infectious Disorders), vol. 24, no. 3, pp. 26-42, 2024.

E. Jamrozik and M. J. Selgelid, "Drug-resistant infection: Causes, consequences, and

responses," Ethics and drug resistance: Collective responsibility for global public health, pp.

-18, 2020.

A. K. Mittal, R. Bhardwaj, P. Mishra, and S. K. Rajput, "Antimicrobials misuse/overuse:

adverse effect, mechanism, challenges and strategies to combat resistance," The Open

Biotechnology Journal, vol. 14, no. 1, 2020.

M. Mustafa and J.-Y. Winum, "The importance of sulfur-containing motifs in drug design and

discovery," Expert Opinion on Drug Discovery, vol. 17, no. 5, pp. 501-512, 2022.

S. Carradori, P. Guglielmi, G. Luisi, and D. Secci, "Nitrogen-and Sulfur-Containing

Heterocycles as Dual Anti-oxidant and Anti-cancer Agents," in Handbook of Oxidative Stress

in Cancer: Mechanistic Aspects: Springer, 2022, pp. 2571-2588.

S. Carradori, P. Guglielmi, G. Luisi, and D. Secci, "Nitrogen-and Sulfur-Containing

Heterocycles as Dual Anti-oxidant and Anti-cancer Agents," Handbook of Oxidative Stress in

Cancer: Mechanistic Aspects, pp. 1-18, 2020.

B. Jia et al., "Degradable biomedical elastomers: paving the future of tissue repair and

regenerative medicine," Chemical Society Reviews, 2024.

G. Huang, T. Cierpicki, and J. Grembecka, "2-Aminobenzothiazoles in anticancer drug design

and discovery," Bioorganic chemistry, p. 106477, 2023.

S. K. Debnath, M. Debnath, and R. Srivastava, "Opportunistic etiological agents causing lung

infections: emerging need to transform lung-targeted delivery," Heliyon, vol. 8, no. 12, 2022.

A. Ovung and J. Bhattacharyya, "Sulfonamide drugs: Structure, antibacterial property,

toxicity, and biophysical interactions," Biophysical reviews, vol. 13, no. 2, pp. 259-272, 2021.

M. Conde-Cid, A. Núñez-Delgado, M. J. Fernández-Sanjurjo, E. Álvarez-Rodríguez, D.

Fernández-Calviño, and M. Arias-Estévez, "Tetracycline and sulfonamide antibiotics in soils:

presence, fate and environmental risks," Processes, vol. 8, no. 11, p. 1479, 2020.